These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2219272)
1. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Cramer DV; Chapman FA; Wu GD; Harnaha JB; Qian SQ; Makowka L Transplantation; 1990 Oct; 50(4):554-8. PubMed ID: 2219272 [TBL] [Abstract][Full Text] [Related]
2. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Koskinen PK; Lemström KB; Häyry PJ Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397 [TBL] [Abstract][Full Text] [Related]
4. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related]
5. Influence of gender on allograft rejection in a rat heart transplant model. Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts. Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761 [TBL] [Abstract][Full Text] [Related]
7. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection. Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952 [TBL] [Abstract][Full Text] [Related]
8. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts. Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247 [TBL] [Abstract][Full Text] [Related]
10. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471 [TBL] [Abstract][Full Text] [Related]
11. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K; Hardy MA; Oluwole SF Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts. Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746 [TBL] [Abstract][Full Text] [Related]
13. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells. Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913 [TBL] [Abstract][Full Text] [Related]
14. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model. Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711 [TBL] [Abstract][Full Text] [Related]
15. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft. Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227 [TBL] [Abstract][Full Text] [Related]
16. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat. Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876 [TBL] [Abstract][Full Text] [Related]
17. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats. Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050 [TBL] [Abstract][Full Text] [Related]
18. Prolonged survival of skin allografts in rats treated with antigen and hydrocortisone and the trend in graft-versus-host reactions. Chutná J; Hasek M Folia Biol (Praha); 1975; 21(4):219-27. PubMed ID: 241669 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116 [TBL] [Abstract][Full Text] [Related]